Natural and age-related variation in circulating human hematopoietic stem cells

Nili Furer, Nadav Rappoport, O. Milman, Aviezer Lifshitz, Abraham Bercovich, Oren Ben-Kiki, Avinoam Danin, Merav Kedmi, Zohar Shipony, Doron Lipson, Eti Meiri, Goichi Yanai, Shiran Shapira, Nadir Arber, S. Berdichevsky, Sigal Tavor, Jeffrey Tyner, Sunil K. Joshi, David Landau, Saravanan Ganesan, Neville Dusaj, Paulina Chamely, Nathali Kaushansky, Noa Chapal-Ilani, Ron Shamir, Amos Tanay, Li ShlushbioRxiv 2023 · DOI

Abstract

Hematopoietic stem and progenitor cells (HSPCs) are responsible for the lifelong production of all blood lineages. As humans age, the hematopoietic system undergoes characteristic changes, including shifts in blood counts and the emergence of clonal hematopoiesis (CH). Understanding the transition from healthy aging to hematological malignancy requires a high-resolution map of inter-individual variation. In this study, we analyzed 627,000 single circulating CD34+ HSPCs (cHSPCs) from 148 healthy individuals. By integrating clinical data and CH profiles, we characterized population-wide hematopoietic variability. We identified a significant reduction in lymphoid progenitors linked to aging (predominantly in males) and the presence of CH. Furthermore, we identified a transcriptional Lamin-A signature and a "synchronization score" that correlate with aging and macrocytic anemia. This healthy cHSPC reference provides a robust framework for identifying myeloid malignancies and pre-malignant states through compositional and transcriptional deviations.

Introduction

The bone marrow serves as the primary "factory" for blood production, but its relative inaccessibility in healthy populations has limited our understanding of normal hematopoietic variation. While bone marrow biopsies are the gold standard, the rare stem cells that leak into the peripheral blood—circulating HSPCs (cHSPCs)—offer a non-invasive window into this system. This research addresses the critical need for a baseline of "normal" variation to better distinguish healthy aging from the early stages of chronic and acute hematological disorders.

Methodology

The research team employed single-cell RNA sequencing (scRNAseq) on CD34+ cells extracted from the peripheral blood of a diverse donor cohort. To ensure data quality and cost-efficiency, the study utilized several innovative computational approaches:

  • Multiplexing and Demultiplexing: Cells from multiple donors were pooled and later assigned to individuals using naturally occurring genetic variations (SNPs), effectively eliminating technical "batch effects."
  • Metacell Modeling: Using the Metacell2 algorithm, individual noisy cells were grouped into highly similar "metacells," allowing for a more granular and stable view of distinct cell states.
  • Sync-Score Development: A novel "synchronization score" was created to quantify the coordination between the downregulation of stemness genes and the activation of differentiation programs.
  • Clinical Correlation: The cellular data were cross-referenced with five years of longitudinal complete blood count (CBC) data and deep targeted sequencing to identify pre-malignant mutations.

Mapping the cHSPC Landscape

A primary finding of the study is that cHSPCs are excellent surrogates for bone marrow HSPCs. The atlas successfully captured rare populations, such as HLF/AVP+ stem cells, which were previously thought to be largely confined to the marrow. Within the circulating CD34+ population, hematopoietic stem cells (HSCs) constitute approximately 1.8%, while more advanced progenitors (such as MPP/MEBEMP) exhibit significantly higher variability between individuals.

Aging, Clonal Hematopoiesis, and the "3-Way Linkage"

The study identified a significant "3-way linkage" between three distinct factors: reduced lymphoid progenitor frequencies, elevated Red Cell Distribution Width (RDW), and the presence of clonal mutations. This suggests that "silent" mutations associated with clonal hematopoiesis (CH) do not just affect the mutant clone itself but exert a systemic effect on the entire stem cell ecosystem.

Key molecular markers of this shift include:

  • Lamin-A (LMNA) Fingerprint: A transcriptional signature involving the LMNA gene—critical for nuclear structural integrity—was found to be consistently lower in individuals with CH and advanced age. This signature may serve as a molecular indicator of an aging or stressed hematopoietic system.
  • Developmental Asynchrony: The "sync-score" revealed that aging is characterized by a breakdown in the timing of cell differentiation. In some older individuals, the coordination between maintaining stemness and initiating differentiation becomes decoupled, a phenomenon that correlates directly with lower red blood cell counts and macrocytosis (enlarged red blood cells).

Diagnostic and Clinical Implications

By establishing a robust reference of healthy cHSPC variation, the researchers demonstrated a proof-of-concept for diagnosing myeloid malignancies. When cells from patients with Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) were projected onto the healthy atlas, deviant cell populations and sub-clones became immediately apparent.

In one specific case of AML, the atlas identified a sub-clone overexpressing BCL2. This level of resolution could allow clinicians to identify specific therapeutic targets—such as BCL2 inhibitors—that might otherwise be overlooked by standard diagnostic tools.

Conclusion

This single-cell atlas of circulating blood stem cells provides a comprehensive resource for understanding human hematopoietic variation. By identifying the molecular signatures of aging and clonal expansion, such as the LMNA signature and the sync-score, this work paves the way for early detection and personalized treatment of blood cancers. While the dynamics of how these cells exit the bone marrow require further study, the use of peripheral blood as a diagnostic mirror offers a promising, minimally invasive path forward for hematological monitoring.

Summary updated

Abstract

Abstract Hematopoietic stem and progenitor cells (HSPCs) deliver life-long multi-lineage output. However, with aging, we exhibit certain characteristic blood count changes and accumulation of clonal disorders. Better understanding of inter-individual variation in HSPC behavior is needed to understand these age-related phenomena and the transition from health to chronic and acute hematological malignancies. Here we study 627K single circulating CD34+ HSPCs (cHSPCs) from 148 healthy individuals, along with their clinical information and clonal hematopoiesis (CH) profiles, to characterize population-wide and age-related hematopoietic variability. Individuals with CH were linked with reduced frequencies of lymphocyte progenitors and higher RDW. An age-related decrease in lymphoid progenitors was observed, predominantly in males. Inter-individual transcriptional variation in expression of a Lamin-A signature and stemness gene programs were linked with aging and presence of macrocytic anemia. Based on our model for healthy cHSPC variation we construct the normal reference for cHSPC subtype frequencies. We show how compositional and expression deviations from this normal reference can robustly identify myeloid malignancies and pre-malignant states. Together, our data and methodologies present a novel resource, shedding light on various age-related hematopoietic processes, and a comprehensive normal cHSPC reference, which can serve as a tool for diagnosing and characterizing hematological disorders.
BibTeX
@misc{furer2023natural,
  author = {Nili Furer and Nadav Rappoport and O. Milman and Aviezer Lifshitz and Abraham Bercovich and Oren Ben-Kiki and Avinoam Danin and Merav Kedmi and Zohar Shipony and Doron Lipson and Eti Meiri and Goichi Yanai and Shiran Shapira and Nadir Arber and S. Berdichevsky and Sigal Tavor and Jeffrey Tyner and Sunil K. Joshi and David Landau and Saravanan Ganesan and Neville Dusaj and Paulina Chamely and Nathali Kaushansky and Noa Chapal-Ilani and Ron Shamir and Amos Tanay and LI Shlush},
  title = {{Natural and age-related variation in circulating human hematopoietic stem cells}},
  year = {2023},
  doi = {10.1101/2023.11.30.569167},
  howpublished = {bioRxiv},
}
Figure